 | • レポートコード：QYR2104Z5408 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、脊椎生物製剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（骨移植片、骨移植片代替物、多血小板血漿（PRP）、BMAC（骨髄穿刺液濃縮物））、用途別市場規模（前頸部椎間板切除術・固定術、後方腰椎椎体間固定術、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脊椎生物製剤の市場動向 ・企業の競争状況、市場シェア ・脊椎生物製剤の種類別市場規模（骨移植片、骨移植片代替物、多血小板血漿（PRP）、BMAC（骨髄穿刺液濃縮物）） ・脊椎生物製剤の用途別市場規模（前頸部椎間板切除術・固定術、後方腰椎椎体間固定術、その他） ・脊椎生物製剤の北米市場規模2016-2027（アメリカ、カナダ） ・脊椎生物製剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脊椎生物製剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脊椎生物製剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・脊椎生物製剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medtronic、Depuy Synthes、Stryker Corporation、Nuvasive、Zimmer Biomet、Orthofix International、Globus Medical、alphatec spine、K2M、Exactech、Wright Medical Technology、X-Spine、Nutech、Arthrex） ・結論 |
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.
Market Analysis and Insights: Global Spine Biologics Market
The global Spine Biologics market size is projected to reach US$ 2825.4 million by 2026, from US$ 2214.8 million in 2019, at a CAGR of 3.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spine Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spine Biologics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spine Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spine Biologics market.
Global Spine Biologics Scope and Market Size
Spine Biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spine Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Segment by Application
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Nuvasive
Zimmer Biomet
X-Spine
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spine Biologics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Market by Application
1.3.1 Global Spine Biologics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Spine Biologics Market Perspective (2016-2027)
2.2 Spine Biologics Growth Trends by Regions
2.2.1 Spine Biologics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spine Biologics Historic Market Share by Regions (2016-2021)
2.2.3 Spine Biologics Forecasted Market Size by Regions (2022-2027)
2.3 Spine Biologics Industry Dynamic
2.3.1 Spine Biologics Market Trends
2.3.2 Spine Biologics Market Drivers
2.3.3 Spine Biologics Market Challenges
2.3.4 Spine Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spine Biologics Players by Revenue
3.1.1 Global Top Spine Biologics Players by Revenue (2016-2021)
3.1.2 Global Spine Biologics Revenue Market Share by Players (2016-2021)
3.2 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spine Biologics Revenue
3.4 Global Spine Biologics Market Concentration Ratio
3.4.1 Global Spine Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spine Biologics Revenue in 2020
3.5 Spine Biologics Key Players Head office and Area Served
3.6 Key Players Spine Biologics Product Solution and Service
3.7 Date of Enter into Spine Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spine Biologics Breakdown Data by Type
4.1 Global Spine Biologics Historic Market Size by Type (2016-2021)
4.2 Global Spine Biologics Forecasted Market Size by Type (2022-2027)
5 Spine Biologics Breakdown Data by Application
5.1 Global Spine Biologics Historic Market Size by Application (2016-2021)
5.2 Global Spine Biologics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Spine Biologics Market Size (2016-2027)
6.2 North America Spine Biologics Market Size by Type
6.2.1 North America Spine Biologics Market Size by Type (2016-2021)
6.2.2 North America Spine Biologics Market Size by Type (2022-2027)
6.2.3 North America Spine Biologics Market Size by Type (2016-2027)
6.3 North America Spine Biologics Market Size by Application
6.3.1 North America Spine Biologics Market Size by Application (2016-2021)
6.3.2 North America Spine Biologics Market Size by Application (2022-2027)
6.3.3 North America Spine Biologics Market Size by Application (2016-2027)
6.4 North America Spine Biologics Market Size by Country
6.4.1 North America Spine Biologics Market Size by Country (2016-2021)
6.4.2 North America Spine Biologics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Spine Biologics Market Size (2016-2027)
7.2 Europe Spine Biologics Market Size by Type
7.2.1 Europe Spine Biologics Market Size by Type (2016-2021)
7.2.2 Europe Spine Biologics Market Size by Type (2022-2027)
7.2.3 Europe Spine Biologics Market Size by Type (2016-2027)
7.3 Europe Spine Biologics Market Size by Application
7.3.1 Europe Spine Biologics Market Size by Application (2016-2021)
7.3.2 Europe Spine Biologics Market Size by Application (2022-2027)
7.3.3 Europe Spine Biologics Market Size by Application (2016-2027)
7.4 Europe Spine Biologics Market Size by Country
7.4.1 Europe Spine Biologics Market Size by Country (2016-2021)
7.4.2 Europe Spine Biologics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Spine Biologics Market Size (2016-2027)
8.2 Asia-Pacific Spine Biologics Market Size by Type
8.2.1 Asia-Pacific Spine Biologics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spine Biologics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spine Biologics Market Size by Type (2016-2027)
8.3 Asia-Pacific Spine Biologics Market Size by Application
8.3.1 Asia-Pacific Spine Biologics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spine Biologics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spine Biologics Market Size by Application (2016-2027)
8.4 Asia-Pacific Spine Biologics Market Size by Region
8.4.1 Asia-Pacific Spine Biologics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spine Biologics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Spine Biologics Market Size (2016-2027)
9.2 Latin America Spine Biologics Market Size by Type
9.2.1 Latin America Spine Biologics Market Size by Type (2016-2021)
9.2.2 Latin America Spine Biologics Market Size by Type (2022-2027)
9.2.3 Latin America Spine Biologics Market Size by Type (2016-2027)
9.3 Latin America Spine Biologics Market Size by Application
9.3.1 Latin America Spine Biologics Market Size by Application (2016-2021)
9.3.2 Latin America Spine Biologics Market Size by Application (2022-2027)
9.3.3 Latin America Spine Biologics Market Size by Application (2016-2027)
9.4 Latin America Spine Biologics Market Size by Country
9.4.1 Latin America Spine Biologics Market Size by Country (2016-2021)
9.4.2 Latin America Spine Biologics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spine Biologics Market Size (2016-2027)
10.2 Middle East & Africa Spine Biologics Market Size by Type
10.2.1 Middle East & Africa Spine Biologics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spine Biologics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spine Biologics Market Size by Type (2016-2027)
10.3 Middle East & Africa Spine Biologics Market Size by Application
10.3.1 Middle East & Africa Spine Biologics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spine Biologics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spine Biologics Market Size by Application (2016-2027)
10.4 Middle East & Africa Spine Biologics Market Size by Country
10.4.1 Middle East & Africa Spine Biologics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spine Biologics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Spine Biologics Introduction
11.1.4 Medtronic Revenue in Spine Biologics Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Depuy Synthes
11.2.1 Depuy Synthes Company Details
11.2.2 Depuy Synthes Business Overview
11.2.3 Depuy Synthes Spine Biologics Introduction
11.2.4 Depuy Synthes Revenue in Spine Biologics Business (2016-2021)
11.2.5 Depuy Synthes Recent Development
11.3 Stryker Corporation
11.3.1 Stryker Corporation Company Details
11.3.2 Stryker Corporation Business Overview
11.3.3 Stryker Corporation Spine Biologics Introduction
11.3.4 Stryker Corporation Revenue in Spine Biologics Business (2016-2021)
11.3.5 Stryker Corporation Recent Development
11.4 Nuvasive
11.4.1 Nuvasive Company Details
11.4.2 Nuvasive Business Overview
11.4.3 Nuvasive Spine Biologics Introduction
11.4.4 Nuvasive Revenue in Spine Biologics Business (2016-2021)
11.4.5 Nuvasive Recent Development
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Company Details
11.5.2 Zimmer Biomet Business Overview
11.5.3 Zimmer Biomet Spine Biologics Introduction
11.5.4 Zimmer Biomet Revenue in Spine Biologics Business (2016-2021)
11.5.5 Zimmer Biomet Recent Development
11.6 Orthofix International
11.6.1 Orthofix International Company Details
11.6.2 Orthofix International Business Overview
11.6.3 Orthofix International Spine Biologics Introduction
11.6.4 Orthofix International Revenue in Spine Biologics Business (2016-2021)
11.6.5 Orthofix International Recent Development
11.7 Globus Medical
11.7.1 Globus Medical Company Details
11.7.2 Globus Medical Business Overview
11.7.3 Globus Medical Spine Biologics Introduction
11.7.4 Globus Medical Revenue in Spine Biologics Business (2016-2021)
11.7.5 Globus Medical Recent Development
11.8 alphatec spine
11.8.1 alphatec spine Company Details
11.8.2 alphatec spine Business Overview
11.8.3 alphatec spine Spine Biologics Introduction
11.8.4 alphatec spine Revenue in Spine Biologics Business (2016-2021)
11.8.5 alphatec spine Recent Development
11.9 K2M
11.9.1 K2M Company Details
11.9.2 K2M Business Overview
11.9.3 K2M Spine Biologics Introduction
11.9.4 K2M Revenue in Spine Biologics Business (2016-2021)
11.9.5 K2M Recent Development
11.10 Exactech
11.10.1 Exactech Company Details
11.10.2 Exactech Business Overview
11.10.3 Exactech Spine Biologics Introduction
11.10.4 Exactech Revenue in Spine Biologics Business (2016-2021)
11.10.5 Exactech Recent Development
11.11 Wright Medical Technology
11.11.1 Wright Medical Technology Company Details
11.11.2 Wright Medical Technology Business Overview
11.11.3 Wright Medical Technology Spine Biologics Introduction
11.11.4 Wright Medical Technology Revenue in Spine Biologics Business (2016-2021)
11.11.5 Wright Medical Technology Recent Development
11.12 X-Spine
11.12.1 X-Spine Company Details
11.12.2 X-Spine Business Overview
11.12.3 X-Spine Spine Biologics Introduction
11.12.4 X-Spine Revenue in Spine Biologics Business (2016-2021)
11.12.5 X-Spine Recent Development
11.13 Nutech
11.13.1 Nutech Company Details
11.13.2 Nutech Business Overview
11.13.3 Nutech Spine Biologics Introduction
11.13.4 Nutech Revenue in Spine Biologics Business (2016-2021)
11.13.5 Nutech Recent Development
11.14 Arthrex
11.14.1 Arthrex Company Details
11.14.2 Arthrex Business Overview
11.14.3 Arthrex Spine Biologics Introduction
11.14.4 Arthrex Revenue in Spine Biologics Business (2016-2021)
11.14.5 Arthrex Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Spine Biologics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bone Graft
Table 3. Key Players of Bone Graft Substitute
Table 4. Key Players of Platelet Rich Plasma (PRP)
Table 5. Key Players of BMAC (Bone Marrow Aspirate Concentrate)
Table 6. Global Spine Biologics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Spine Biologics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Spine Biologics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Spine Biologics Market Share by Regions (2016-2021)
Table 10. Global Spine Biologics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Spine Biologics Market Share by Regions (2022-2027)
Table 12. Spine Biologics Market Trends
Table 13. Spine Biologics Market Drivers
Table 14. Spine Biologics Market Challenges
Table 15. Spine Biologics Market Restraints
Table 16. Global Spine Biologics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Spine Biologics Market Share by Players (2016-2021)
Table 18. Global Top Spine Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spine Biologics as of 2020)
Table 19. Ranking of Global Top Spine Biologics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Spine Biologics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Spine Biologics Product Solution and Service
Table 23. Date of Enter into Spine Biologics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Spine Biologics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Spine Biologics Revenue Market Share by Type (2016-2021)
Table 27. Global Spine Biologics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Spine Biologics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Spine Biologics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Spine Biologics Revenue Market Share by Application (2016-2021)
Table 31. Global Spine Biologics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Spine Biologics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Spine Biologics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Spine Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Spine Biologics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Spine Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Spine Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Spine Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Spine Biologics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Spine Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Spine Biologics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Spine Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Spine Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Spine Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Spine Biologics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Spine Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Spine Biologics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Spine Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Spine Biologics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Spine Biologics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Spine Biologics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Spine Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Spine Biologics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Spine Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Spine Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Spine Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Spine Biologics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Spine Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Spine Biologics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Spine Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Spine Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Spine Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Medtronic Company Details
Table 64. Medtronic Business Overview
Table 65. Medtronic Spine Biologics Product
Table 66. Medtronic Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 67. Medtronic Recent Development
Table 68. Depuy Synthes Company Details
Table 69. Depuy Synthes Business Overview
Table 70. Depuy Synthes Spine Biologics Product
Table 71. Depuy Synthes Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 72. Depuy Synthes Recent Development
Table 73. Stryker Corporation Company Details
Table 74. Stryker Corporation Business Overview
Table 75. Stryker Corporation Spine Biologics Product
Table 76. Stryker Corporation Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 77. Stryker Corporation Recent Development
Table 78. Nuvasive Company Details
Table 79. Nuvasive Business Overview
Table 80. Nuvasive Spine Biologics Product
Table 81. Nuvasive Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 82. Nuvasive Recent Development
Table 83. Zimmer Biomet Company Details
Table 84. Zimmer Biomet Business Overview
Table 85. Zimmer Biomet Spine Biologics Product
Table 86. Zimmer Biomet Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 87. Zimmer Biomet Recent Development
Table 88. Orthofix International Company Details
Table 89. Orthofix International Business Overview
Table 90. Orthofix International Spine Biologics Product
Table 91. Orthofix International Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 92. Orthofix International Recent Development
Table 93. Globus Medical Company Details
Table 94. Globus Medical Business Overview
Table 95. Globus Medical Spine Biologics Product
Table 96. Globus Medical Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 97. Globus Medical Recent Development
Table 98. alphatec spine Company Details
Table 99. alphatec spine Business Overview
Table 100. alphatec spine Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 101. alphatec spine Recent Development
Table 102. K2M Company Details
Table 103. K2M Business Overview
Table 104. K2M Spine Biologics Product
Table 105. K2M Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 106. K2M Recent Development
Table 107. Exactech Company Details
Table 108. Exactech Business Overview
Table 109. Exactech Spine Biologics Product
Table 110. Exactech Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 111. Exactech Recent Development
Table 112. Wright Medical Technology Company Details
Table 113. Wright Medical Technology Business Overview
Table 114. Wright Medical Technology Spine Biologics Product
Table 115. Wright Medical Technology Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 116. Wright Medical Technology Recent Development
Table 117. X-Spine Company Details
Table 118. X-Spine Business Overview
Table 119. X-Spine Spine Biologics Product
Table 120. X-Spine Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 121. X-Spine Recent Development
Table 122. Nutech Company Details
Table 123. Nutech Business Overview
Table 124. Nutech Spine Biologics Product
Table 125. Nutech Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 126. Nutech Recent Development
Table 127. Arthrex Company Details
Table 128. Arthrex Business Overview
Table 129. Arthrex Spine Biologics Product
Table 130. Arthrex Revenue in Spine Biologics Business (2016-2021) & (US$ Million)
Table 131. Arthrex Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spine Biologics Market Share by Type: 2020 VS 2027
Figure 2. Bone Graft Features
Figure 3. Bone Graft Substitute Features
Figure 4. Platelet Rich Plasma (PRP) Features
Figure 5. BMAC (Bone Marrow Aspirate Concentrate) Features
Figure 6. Global Spine Biologics Market Share by Application: 2020 VS 2027
Figure 7. Anterior Cervical Discectomy and Fusion Case Studies
Figure 8. Posterior Lumbar Interbody Fusion Case Studies
Figure 9. Others Case Studies
Figure 10. Spine Biologics Report Years Considered
Figure 11. Global Spine Biologics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Spine Biologics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Spine Biologics Market Share by Regions: 2020 VS 2027
Figure 14. Global Spine Biologics Market Share by Regions (2022-2027)
Figure 15. Global Spine Biologics Market Share by Players in 2020
Figure 16. Global Top Spine Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spine Biologics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Spine Biologics Revenue in 2020
Figure 18. Global Spine Biologics Revenue Market Share by Type (2016-2021)
Figure 19. Global Spine Biologics Revenue Market Share by Type (2022-2027)
Figure 20. North America Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Spine Biologics Market Share by Type (2016-2027)
Figure 22. North America Spine Biologics Market Share by Application (2016-2027)
Figure 23. North America Spine Biologics Market Share by Country (2016-2027)
Figure 24. United States Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Spine Biologics Market Share by Type (2016-2027)
Figure 28. Europe Spine Biologics Market Share by Application (2016-2027)
Figure 29. Europe Spine Biologics Market Share by Country (2016-2027)
Figure 30. Germany Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Spine Biologics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Spine Biologics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Spine Biologics Market Share by Region (2016-2027)
Figure 40. China Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Spine Biologics Market Share by Type (2016-2027)
Figure 48. Latin America Spine Biologics Market Share by Application (2016-2027)
Figure 49. Latin America Spine Biologics Market Share by Country (2016-2027)
Figure 50. Mexico Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Spine Biologics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Spine Biologics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Spine Biologics Market Share by Country (2016-2027)
Figure 56. Turkey Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Spine Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Medtronic Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 60. Depuy Synthes Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 61. Stryker Corporation Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 62. Nuvasive Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 63. Zimmer Biomet Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 64. Orthofix International Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 65. Globus Medical Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 66. alphatec spine Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 67. K2M Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 68. Exactech Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 69. Wright Medical Technology Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 70. X-Spine Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 71. Nutech Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 72. Arthrex Revenue Growth Rate in Spine Biologics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の腰椎固定術市場規模・現状・予測（2021年-2027年） Spinal fusion surgery is performed in many forms, and all are designed to help limit the pain caused by joints through surgery depending on conditions such as degenerative disc disease (DDD), spondylosyndesis or spondylodesis, and other small problems caused in spine vertebrae. Over the recent years…- 世界の外側腰椎椎体間固定術市場規模・現状・予測（2021年-2027年） Spinal fusion is a neurosurgical or orthopedic surgical technique that joins two or more vertebrae. This procedure can be performed at any level in the spine (cervical, thoracic, or lumbar) and prevents any movement between the fused vertebrae. There are many types of spinal fusion and each techniqu…
- 世界の生分解性骨移植ポリマー市場規模・現状・予測（2021年-2027年） Biodegradable Bone Graft Polymers is profoundly carving an evolution tale from conventional allogeneic and autologous bone grafting techniques to synthetic bone grafts, primarily on account of the biodegradability and biocompatibility properties of the latter. Synthetic bone graft polymers are capab…
- 世界の生分解性骨移植ポリマー市場規模・現状・予測（2021年-2027年） Biodegradable Bone Graft Polymers is profoundly carving an evolution tale from conventional allogeneic and autologous bone grafting techniques to synthetic bone grafts, primarily on account of the biodegradability and biocompatibility properties of the latter. Synthetic bone graft polymers are capab…
- 世界の腰椎椎体間固定ケージ市場 2021：企業別、地域別、種類・用途別 The Lumbar Interbody Fusion Cages market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…